SRRK
NASDAQ · Biotechnology
Scholar Rock Holding Corp
$45.50
-0.59 (-1.28%)
Performance
1D
—
1W
+3.64%
1M
+7.82%
3M
-12.31%
6M
-5.89%
1Y
+57.99%
YTD
+6.31%
Open$45.74
Previous Close$46.09
Day High$46.00
Day Low$43.86
52W High$61.76
52W Low$27.07
Volume—
Avg Volume1.87M
Market Cap5.26B
P/E Ratio—
EPS$-3.30
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$47.67
Below
SMA 200
$48.19
Below
RSI (14)
71.8
Overbought
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
24 analysts
Price Target
+56.7% upside
Current
$45.50
$45.50
Target
$71.29
$71.29
$54.07
$71.29 avg
$91.55
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 910.50M | 880.80M | 846.68M |
| Net Income | -11,497,538 | -12,296,426 | -11,692,649 |
| Profit Margin | -1.3% | -1.4% | -1.4% |
| EBITDA | -11,509,292 | -12,212,052 | -11,111,961 |
| Free Cash Flow | -10,999,659 | -14,100,591 | -9,156,076 |
| Rev Growth | +11.0% | +3.4% | +15.4% |
| Debt/Equity | 0.75 | 0.83 | 0.78 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |